Bastiano Sanna

Insider Reports History

Entity
Individual
Location
C/O Vertex Pharmaceuticals Incorporated, 50 Northern Avenue, Boston, Massachusetts
Signature
/s/ Nick Harvey, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bastiano Sanna:

Stock Role Class Num Shares Value Price $ Report Date Ownership
VERTEX PHARMACEUTICALS INC / MA EVP, Cell & Genetic Therapies Common Stock 32,038 $13.4 M $419.07 May 8, 2023 Direct
Adicet Bio, Inc. Director Common Stock 5,900 $7.97 K $1.35 Jun 1, 2023 Direct
Adicet Bio, Inc. Director Stock Option (Right to Buy) 26,400 Aug 14, 2023 Direct

Insider Reports Filed by Bastiano Sanna

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACET Adicet Bio, Inc. Aug 14, 2023 10 0 4 Aug 16, 2023 Director
ACET Adicet Bio, Inc. Jun 1, 2023 2 0 4 Jun 2, 2023 Director
VRTX VERTEX PHARMACEUTICALS INC / MA May 5, 2023 2 -1,145,213 4 May 9, 2023 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA May 2, 2023 5 -1,544,187 4 May 4, 2023 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA Apr 12, 2023 3 -2,472,164 4 Apr 14, 2023 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA Apr 4, 2023 5 -164,854 4 Apr 6, 2023 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA Mar 31, 2023 1 -459,943 4 Apr 4, 2023 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA Mar 16, 2023 2 -825,423 4 Mar 20, 2023 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 24, 2023 1 -1,147,806 4 Feb 28, 2023 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 17, 2023 1 -1,098,188 4 Feb 22, 2023 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 14, 2023 2 -655,161 4 Feb 16, 2023 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 10, 2023 3 -1,593,878 4 Feb 14, 2023 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 1, 2023 3 0 4 Feb 3, 2023 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA Jan 31, 2023 1 -34,450 4 Feb 2, 2023 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA Nov 1, 2022 8 -340,306 4 Nov 3, 2022 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA Oct 18, 2022 2 -537,860 4 Oct 20, 2022 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA Aug 1, 2022 1 -211,891 4 Aug 3, 2022 EVP, Cell & Genetic Therapies
ACET Adicet Bio, Inc. Jun 2, 2022 1 0 4 Jun 3, 2022 Director
VRTX VERTEX PHARMACEUTICALS INC / MA May 16, 2022 5 -11,377 4 May 18, 2022 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA May 4, 2022 1 -9,903 4 May 6, 2022 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA May 2, 2022 7 -82,930 4 May 4, 2022 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA Apr 29, 2022 1 -211,546 4 May 3, 2022 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA Apr 7, 2022 3 -154,935 4 Apr 8, 2022 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA Apr 4, 2022 3 -1,021,005 4 Apr 6, 2022 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA Apr 1, 2022 1 -353,593 4 Apr 5, 2022 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA Mar 17, 2022 1 -530,627 4 Mar 21, 2022 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 17, 2022 1 -799,602 4 Feb 22, 2022 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 10, 2022 1 -232,747 4 Feb 14, 2022 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA Feb 1, 2022 8 -389,172 4 Feb 3, 2022 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA Nov 1, 2021 1 -141,764 4 Nov 3, 2021 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA Jul 30, 2021 1 -153,499 4 Aug 3, 2021 EVP, Cell & Genetic Therapies
VRTX VERTEX PHARMACEUTICALS INC / MA May 17, 2021 2 -24,230 4 May 19, 2021 EVP, Cell & Genetic Therapies